发明名称 |
Therapeutic agents |
摘要 |
The present invention provides the S enantiomer of a compound of formula I wherein R<SUP>1 </SUP>represents chloro, trifluoromethyl or trifluoromethoxy, R<SUP>2 </SUP>represents H or fluoro and R<SUP>3 </SUP>represents a C<SUB>2-4</SUB>alkyl group as well as pharmaceutically acceptable salts, solvates and prodrugs thereof, to processes for preparing such compounds, to their the utility in treating clinical conditions including lipid disorders (dyslipidemias) whether or not associated with insulin resistance, to methods for their therapeutic use and to pharmaceutical compositions containing them.
|
申请公布号 |
US2005131068(A1) |
申请公布日期 |
2005.06.16 |
申请号 |
US20040499893 |
申请日期 |
2004.06.23 |
申请人 |
ALSTERMARK EVA-LOTTE L.;OLSSON ANNA, CRISTINA;LI LANNA;AURELL CARL-JOHAN;MINIDIS ANNA;YOUSEFI-SALAKDEH ESMAIL;DAHLSTROM MIKAEL, ULF, JOHAN |
发明人 |
ALSTERMARK EVA-LOTTE L.;OLSSON ANNA, CRISTINA;LI LANNA;AURELL CARL-JOHAN;MINIDIS ANNA;YOUSEFI-SALAKDEH ESMAIL;DAHLSTROM MIKAEL, ULF, JOHAN |
分类号 |
A61K31/16;C07C235/20;(IPC1-7):A61K31/195;C07C233/45 |
主分类号 |
A61K31/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|